1. Home
  2. UPBD vs RLAY Comparison

UPBD vs RLAY Comparison

Compare UPBD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • RLAY
  • Stock Information
  • Founded
  • UPBD 1986
  • RLAY 2015
  • Country
  • UPBD United States
  • RLAY United States
  • Employees
  • UPBD N/A
  • RLAY N/A
  • Industry
  • UPBD Diversified Commercial Services
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UPBD Consumer Discretionary
  • RLAY Health Care
  • Exchange
  • UPBD Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • UPBD 1.0B
  • RLAY 1.0B
  • IPO Year
  • UPBD 1995
  • RLAY 2020
  • Fundamental
  • Price
  • UPBD $17.58
  • RLAY $6.78
  • Analyst Decision
  • UPBD Strong Buy
  • RLAY Strong Buy
  • Analyst Count
  • UPBD 4
  • RLAY 9
  • Target Price
  • UPBD $32.50
  • RLAY $16.00
  • AVG Volume (30 Days)
  • UPBD 980.8K
  • RLAY 2.4M
  • Earning Date
  • UPBD 10-30-2025
  • RLAY 11-06-2025
  • Dividend Yield
  • UPBD 8.97%
  • RLAY N/A
  • EPS Growth
  • UPBD N/A
  • RLAY N/A
  • EPS
  • UPBD 1.45
  • RLAY N/A
  • Revenue
  • UPBD $4,577,844,000.00
  • RLAY $8,355,000.00
  • Revenue This Year
  • UPBD $10.26
  • RLAY $27.30
  • Revenue Next Year
  • UPBD $7.68
  • RLAY $7.43
  • P/E Ratio
  • UPBD $11.98
  • RLAY N/A
  • Revenue Growth
  • UPBD 7.48
  • RLAY N/A
  • 52 Week Low
  • UPBD $15.82
  • RLAY $1.78
  • 52 Week High
  • UPBD $36.00
  • RLAY $7.64
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 38.48
  • RLAY 56.61
  • Support Level
  • UPBD $15.82
  • RLAY $6.17
  • Resistance Level
  • UPBD $17.22
  • RLAY $6.76
  • Average True Range (ATR)
  • UPBD 0.73
  • RLAY 0.43
  • MACD
  • UPBD -0.02
  • RLAY -0.05
  • Stochastic Oscillator
  • UPBD 41.57
  • RLAY 76.04

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: